Sachi Bio publishes on immunotherapy drug-development in Life Sciences in Space Research
- anushreechatterjee6
- May 11, 2022
- 2 min read
Updated: Feb 2, 2023

May 11, 2022
Immune suppression poses significant health challenges for millions of patients undergoing cancer chemotherapy and radiotherapy treatment, and astronauts and space tourists travelling to outer space due to radiation-induced immune dysfunction. While a limited number of recombinant protein therapies, such a Sargramostim, are approved for accelerating hematologic recovery, the pronounced role of granulocyte-macrophage colony-stimulating factor (GM-CSF or CSF2) as a proinflammatory cytokine poses additional challenges in creating immune dysfunction towards pathogenic autoimmune diseases.